These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38991952)

  • 1. [Basic research in sepsis: advances and challenges].
    Wu M; Bai J; Yan Y; Xie X; Ma C; Du X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Jun; 36(6):561-566. PubMed ID: 38991952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of high mobility group box-1 protein in severe sepsis.
    Sunden-Cullberg J; Norrby-Teglund A; Treutiger CJ
    Curr Opin Infect Dis; 2006 Jun; 19(3):231-6. PubMed ID: 16645483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of high mobility group box 1, von Willebrand factor and other cytokines in the evaluation of severity and prognosis of sepsis patients].
    Chen Y; Huang X; Kong G; Liu X; Tian H; Lyu B; Ning F; Wang T; Hao D
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Aug; 32(8):933-937. PubMed ID: 32912405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in high mobility group box-1 protein mediated multiple organ dysfunction and its potential interventional strategies].
    Yao YM; Xu S; Sheng ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Aug; 29(4):459-65. PubMed ID: 19209785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of postoperative HLA-DR expression and high mobility group box 1 level in predictive diagnosis of sepsis in percutaneous nephrolithotomy surgery.
    Hou HF; Liu Y; Zhang X; Han Z; Chen T
    Ren Fail; 2022 Dec; 44(1):1338-1344. PubMed ID: 35930298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High mobility group box 1 as a biomarker in critically ill patients.
    Yagmur E; Buendgens L; Herbers U; Beeretz A; Weiskirchen R; Koek GH; Trautwein C; Tacke F; Koch A
    J Clin Lab Anal; 2018 Oct; 32(8):e22584. PubMed ID: 29862569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High plasma levels of high mobility group box 1 is associated with the risk of sepsis in severe blunt chest trauma patients: a prospective cohort study.
    Wang XW; Karki A; Zhao XJ; Xiang XY; Lu ZQ
    J Cardiothorac Surg; 2014 Aug; 9():133. PubMed ID: 25085006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum HMGB1 and soluble urokinase plasminogen activator receptor levels aid diagnosis and prognosis prediction of sepsis with acute respiratory distress syndrome.
    Fan Y; Ye Z; Tang Y
    Biomark Med; 2023 Feb; 17(4):231-239. PubMed ID: 37158106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenectomy protects against sepsis lethality and reduces serum HMGB1 levels.
    Huston JM; Wang H; Ochani M; Ochani K; Rosas-Ballina M; Gallowitsch-Puerta M; Ashok M; Yang L; Tracey KJ; Yang H
    J Immunol; 2008 Sep; 181(5):3535-9. PubMed ID: 18714026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between HMGB1 gene polymorphisms and susceptibility and clinical outcomes in Chinese Han sepsis patients.
    Qiu P; Wang L; Ni J; Zhang Y
    Gene; 2019 Mar; 687():23-29. PubMed ID: 30423384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for Sepsis Induced by Infections: Clinical Evidence and Potential Targets.
    Huang SJ; Ai T; Hu H; Wang J; Wang JL
    Discov Med; 2022; 34(172):83-95. PubMed ID: 36281029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Mobility Group Box 1 (HMGB1): Potential Target in Sepsis-Associated Encephalopathy.
    DeWulf B; Minsart L; Verdonk F; Kruys V; Piagnerelli M; Maze M; Saxena S
    Cells; 2023 Apr; 12(7):. PubMed ID: 37048161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-mobility group box 1 mediates persistent splenocyte priming in sepsis survivors: evidence from a murine model.
    Valdés-Ferrer SI; Rosas-Ballina M; Olofsson PS; Lu B; Dancho ME; Li J; Yang H; Pavlov VA; Chavan SS; Tracey KJ
    Shock; 2013 Dec; 40(6):492-5. PubMed ID: 24089009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sepsis in the era of data-driven medicine: personalizing risks, diagnoses, treatments and prognoses.
    Liu AC; Patel K; Vunikili RD; Johnson KW; Abdu F; Belman SK; Glicksberg BS; Tandale P; Fontanez R; Mathew OK; Kasarskis A; Mukherjee P; Subramanian L; Dudley JT; Shameer K
    Brief Bioinform; 2020 Jul; 21(4):1182-1195. PubMed ID: 31190075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased concentrations of C-reactive protein but not high-mobility group box 1 in dogs with naturally occurring sepsis.
    Karlsson I; Wernersson S; Ambrosen A; Kindahl H; Södersten F; Wang L; Hagman R
    Vet Immunol Immunopathol; 2013 Nov; 156(1-2):64-72. PubMed ID: 24120445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-decade journey in identifying high mobility group box 1 (HMGB1) and procathepsin L (pCTS-L) as potential therapeutic targets for sepsis.
    Li J; Zhu CS; He L; Qiang X; Chen W; Wang H
    Expert Opin Ther Targets; 2023; 27(7):575-591. PubMed ID: 37477229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis.
    Karlsson S; Pettilä V; Tenhunen J; Laru-Sompa R; Hynninen M; Ruokonen E
    Intensive Care Med; 2008 Jun; 34(6):1046-53. PubMed ID: 18297269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury.
    Deng C; Zhao L; Yang Z; Shang JJ; Wang CY; Shen MZ; Jiang S; Li T; Di WC; Chen Y; Li H; Cheng YD; Yang Y
    Acta Pharmacol Sin; 2022 Mar; 43(3):520-528. PubMed ID: 34040166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics.
    Vijayakumar EC; Bhatt LK; Prabhavalkar KS
    Curr Drug Targets; 2019; 20(14):1474-1485. PubMed ID: 31215389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Dynamic Monitoring of Cellular Immunity and HMGB1 in Severe Sepsis: Delayed Chronic Inflammation may be the Leading Cause of Death in Late Severe Sepsis.
    Yu H; Qi Z; Zhao L; Shao R; Fang Y; Li C
    Clin Lab; 2016 Dec; 62(12):2379-2385. PubMed ID: 28164547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.